Regenxbio RGNX
NASDAQ RGNX
$7.26 -0.14 (-1.82%)
As of: Oct 21, 2026 · 11:41 AM EDT

Regenxbio (RGNX) Total Debt (2014)

Updated

Regenxbio (RGNX) posted Total Debt of $2.4 million for Q4 2014.

Analysis

Regenxbio (RGNX) Total Debt (2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 49.04 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 70.82 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 32.35 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 26.25 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 63.19 Bn
10 Regenxbio 384.79 Mn -548.30 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 2.40 Mn
API Access

Regenxbio Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=RGNX&period=max&api_key=YOUR_API_KEY